Article
Prevention of Acute Sickle Cell Crisis: Review of the NEJM Report
Practical Pain Management
(2016)
Abstract
Commentary on the latest phase 2 results of crizanlizumab, a novel pharmaceutical agent for the prevention of vaso-occlusive crises in patients suffering from sickle cell disease.
Disciplines
Publication Date
December, 2016
DOI
https://www.practicalpainmanagement.com/resources/news-and-research/prevention-acute-sickle-cell-crisis-review-nejm-report
Citation Information
Leonard Goldstein, Victoria A Troncoso and Roya Vahdatinia. "Prevention of Acute Sickle Cell Crisis: Review of the NEJM Report" Practical Pain Management (2016) Available at: http://works.bepress.com/victoria-troncoso/7/